Development and validation of a 6-plex Luminex-based assay for measuring human serum antibodies to group B streptococcus capsular polysaccharides

IF 4.8 4区医学

Human Vaccines & Immunotherapeutics Pub Date : 2024-04-12 DOI:10.1080/21645515.2024.2311480

Michelle A. Gaylord, Melissa Larrier, Donna Giordano-Schmidt, Christopher D. Grube, Suddham Singh, Ha H. Nguyen, Andrew McKeen, Charles Y. Tan, Annaliesa S. Anderson, Warren V. Kalina, Danka Pavliakova, Peter C. Giardina

引用次数: 0

Abstract

Six serotypes (Ia, Ib, II, III, IV, and V) cause nearly all group B streptococcal (GBS) disease globally. Capsular polysaccharide (CPS) conjugate vaccines aim to prevent GBS disease, however, licen...

查看原文本刊更多论文

开发并验证基于 Luminex 的 6 重检测法，用于测量人类血清中的 B 群链球菌荚膜多糖抗体

在全球范围内，六种血清型（Ia、Ib、II、III、IV 和 V）几乎会导致所有的 B 组链球菌 (GBS) 疾病。囊状多糖 (CPS) 结合疫苗旨在预防 GBS 疾病，然而，许可...

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Human Vaccines & Immunotherapeutics BIOTECHNOLOGY & APPLIED MICROBIOLOGY-IMMUNOLOGY

自引率

8.30%

发文量

审稿时长

1 months

期刊介绍： (formerly Human Vaccines; issn 1554-8619) Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics. Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.